Carolyn M Dresler

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint The changing epidemic of lung cancer and occupational and environmental risk factors
    Carolyn Dresler
    Tobacco Prevention and Cessation Network, Arkansas Department of Health, 4815 West Markham Street, Little Rock, AR 72205, USA
    Thorac Surg Clin 23:113-22. 2013
  2. doi request reprint Attitudes of women from five European countries regarding tobacco control policies
    Carolyn Dresler
    1Arkansas Department of Health, Little Rock, USA
    Scand J Public Health 41:126-33. 2013
  3. doi request reprint Human rights-based approach to tobacco control
    Carolyn Dresler
    Arkansas Department of Health, Little Rock, AR 72207, USA
    Tob Control 21:208-11. 2012
  4. ncbi request reprint Is it more important to quit smoking than which chemotherapy is used?
    Carolyn M Dresler
    Lung Cancer 39:119-24. 2003
  5. ncbi request reprint Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion
    Carolyn M Dresler
    Head, Tobacco Unit, International Agency for Research on Cancer, Lyon, France
    Chest 127:909-15. 2005
  6. doi request reprint Epidemiology of lung cancer: smoking, secondhand smoke, and genetics
    Matthew A Steliga
    Division of Cardiothoracic Surgery, University of Arkansas for Medical Sciences, 4301 West Markham Street 713, Little Rock, AR 72205, USA
    Surg Oncol Clin N Am 20:605-18. 2011
  7. ncbi request reprint Reversal of risk upon quitting smoking
    Carolyn M Dresler
    International Agency for Research on Cancer, 150, cours Albert Thomas, 69008, Lyon, France
    Lancet 368:348-9. 2006
  8. ncbi request reprint Cytisine for smoking cessation: a research agenda
    Jean Francois Etter
    Institute of Social and Preventive Medicine, University of Geneva, CMU, Case Postale, CH 1211 Geneva 4, Switzerland
    Drug Alcohol Depend 92:3-8. 2008
  9. ncbi request reprint Response to Perkins and Scott. Nicotine patch and lozenge are effective for women
    Saul Shiffman
    Nicotine Tob Res 8:321-2. 2006
  10. ncbi request reprint Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study
    Howard S Marsh
    GlaxoSmithKline Consumer Healthcare, Parsippany, NJ 07054, USA
    Clin Ther 27:1571-87. 2005

Collaborators

Detail Information

Publications14

  1. doi request reprint The changing epidemic of lung cancer and occupational and environmental risk factors
    Carolyn Dresler
    Tobacco Prevention and Cessation Network, Arkansas Department of Health, 4815 West Markham Street, Little Rock, AR 72205, USA
    Thorac Surg Clin 23:113-22. 2013
    ..There are other causes of lung cancer in people who never smoke, which include environmental and occupational. Enough is now known to implement strong policies that could eliminate most lung cancers...
  2. doi request reprint Attitudes of women from five European countries regarding tobacco control policies
    Carolyn Dresler
    1Arkansas Department of Health, Little Rock, USA
    Scand J Public Health 41:126-33. 2013
    ..Implementing comprehensive smokefree laws will gain high approval and will be associated with prompting people to quit...
  3. doi request reprint Human rights-based approach to tobacco control
    Carolyn Dresler
    Arkansas Department of Health, Little Rock, AR 72207, USA
    Tob Control 21:208-11. 2012
    ..The initial work of the Human Rights and Tobacco Control Network is summarised and considers the future directions for the human rights-based approach to tobacco control...
  4. ncbi request reprint Is it more important to quit smoking than which chemotherapy is used?
    Carolyn M Dresler
    Lung Cancer 39:119-24. 2003
    ..Documentation of smoking status is critical to report in future studies that have evaluated therapeutic options...
  5. ncbi request reprint Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion
    Carolyn M Dresler
    Head, Tobacco Unit, International Agency for Research on Cancer, Lyon, France
    Chest 127:909-15. 2005
    ..To demonstrate the efficacy, safety, and appropriate mode of instillation of talc for sclerosis in treatment of malignant pleural effusions (MPEs)...
  6. doi request reprint Epidemiology of lung cancer: smoking, secondhand smoke, and genetics
    Matthew A Steliga
    Division of Cardiothoracic Surgery, University of Arkansas for Medical Sciences, 4301 West Markham Street 713, Little Rock, AR 72205, USA
    Surg Oncol Clin N Am 20:605-18. 2011
    ..By more fully appreciating the complex interrelationship between genetics and other risks the development of lung cancer can be more completely understood...
  7. ncbi request reprint Reversal of risk upon quitting smoking
    Carolyn M Dresler
    International Agency for Research on Cancer, 150, cours Albert Thomas, 69008, Lyon, France
    Lancet 368:348-9. 2006
  8. ncbi request reprint Cytisine for smoking cessation: a research agenda
    Jean Francois Etter
    Institute of Social and Preventive Medicine, University of Geneva, CMU, Case Postale, CH 1211 Geneva 4, Switzerland
    Drug Alcohol Depend 92:3-8. 2008
    ..Potentially, this research effort, contributing to wider use of an inexpensive drug, could save many lives...
  9. ncbi request reprint Response to Perkins and Scott. Nicotine patch and lozenge are effective for women
    Saul Shiffman
    Nicotine Tob Res 8:321-2. 2006
  10. ncbi request reprint Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study
    Howard S Marsh
    GlaxoSmithKline Consumer Healthcare, Parsippany, NJ 07054, USA
    Clin Ther 27:1571-87. 2005
    ..Nicotine polacrilex lozenges deliver 25% to 27% more nicotine compared with equivalent doses of nicotine polacrilex gum. The increased nicotine exposure from the lozenge has raised questions about the relative safety of the lozenge and gum...
  11. ncbi request reprint Nicotine patch and lozenge are effective for women
    Saul Shiffman
    Pinney Associates and University of Pittsburgh, Pittsburgh, PA 15213, USA
    Nicotine Tob Res 7:119-27. 2005
    ..Treatment with nicotine patch or lozenge is effective for women, and the analysis did not reveal significant gender differences in efficacy. Gender differences in outcome may be moderated by nicotine dependence...
  12. ncbi request reprint Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy
    Saul Shiffman
    Pinney Associates, Pittsburgh, PA, USA
    Addiction 99:83-92. 2004
    ..To assess the influence of unsuccessful past quit attempts using pharmacological treatment on smoking cessation when using a new nicotine lozenge...
  13. ncbi request reprint Pharmacokinetics of a nicotine polacrilex lozenge
    Jae H Choi
    GlaxoSmithKline Consumer Healthcare, Parsippany NJ 07054 3884, USA
    Nicotine Tob Res 5:635-44. 2003
    ..These pharmacokinetic characteristics should allow the lozenge to become an effective and safe therapeutic alternative for smoking cessation...
  14. ncbi request reprint Efficacy of a nicotine lozenge for smoking cessation
    Saul Shiffman
    Pinney Associates, 201 N Craig St, Suite 320, Pittsburgh, PA 15213, USA
    Arch Intern Med 162:1267-76. 2002
    ..Some smokers prefer acute oral forms, but many smokers reject chewing gum. We tested the safety and efficacy of a new nicotine polacrilex lozenge for smoking cessation...